Inhibition of stromal collagen receptor impairs breast cancer metastasis

Research output: Contribution to conferencePoster

Abstract

The majority of cancer-related deaths are due to metastatic disease. Despite advances in identifying major drivers of primary tumour growth and the development of novel targeted therapies, there remains an unmet need to develop treatment strategies targeting metastatic disease. It is now well established that successful tumour progression involves a close crosstalk between tumour cells and the microenvironment.
By combining in silico analysis, in vitro 3D (co-)culture assays and in vivo spontaneous and experimental breast cancer metastasis models we show that inhibition of the stromal collagen receptor Endo180 reduces breast cancer metastasis formation.
Analyses of fibroblast gene signatures show a significant correlation of the collagen receptor Endo180 and fibroblast activation in human breast cancer data sets. Knock-down of Endo180 in normal and activated fibroblasts reduced their contractility on soft and stiff hydrogels. Interestingly these findings were independent of collagen. Endo180 knockdown fibroblasts lost the ability to modulate and contract collagen plugs and were less invasive. Furthermore, knock-down made the fibroblasts more fragile and sensitive towards stressful conditions, such as reduced serum and anchorage independent growth. In 3D co-culture spheroids assays wildtype fibroblasts enhanced tumour spheroid growth in contrast to Endo180 knock-down ones. Dissociation of these spheroids showed a reduced number of fibroblasts in Endo180 knock-down co-culture spheres.
To assess the role of stromal Endo180 in vivo, mouse mammary carcinoma cells were orthotopically inoculated into BALB/c wildtype and knockout animals. Mice lacking the stromal collagen receptor had a significant reduction in primary tumour growth and spontaneous metastasis to the lungs. Experimental metastasis assays confirmed these findings. In correlation with our in vitro spheroid results, reduced fibroblasts infiltration was detected in primary tumours of Endo180 knock-out animals compared to wildtype animals.
These data provide evidence that stromal Endo180 plays an essential role in efficient breast cancer metastasis establishment.
Original languageEnglish
Publication statusPublished - 3 Jul 2019
EventBritish Association of Cancer Research Conference : Tumour Microenvironment - Nottingham, UK United Kingdom
Duration: 1 Jul 20193 Jul 2019

Conference

ConferenceBritish Association of Cancer Research Conference
CountryUK United Kingdom
CityNottingham
Period1/07/193/07/19

Cite this

Jungwirth, U. (2019). Inhibition of stromal collagen receptor impairs breast cancer metastasis. Poster session presented at British Association of Cancer Research Conference , Nottingham, UK United Kingdom.

Inhibition of stromal collagen receptor impairs breast cancer metastasis. / Jungwirth, Ute.

2019. Poster session presented at British Association of Cancer Research Conference , Nottingham, UK United Kingdom.

Research output: Contribution to conferencePoster

Jungwirth, U 2019, 'Inhibition of stromal collagen receptor impairs breast cancer metastasis' British Association of Cancer Research Conference , Nottingham, UK United Kingdom, 1/07/19 - 3/07/19, .
Jungwirth U. Inhibition of stromal collagen receptor impairs breast cancer metastasis. 2019. Poster session presented at British Association of Cancer Research Conference , Nottingham, UK United Kingdom.
Jungwirth, Ute. / Inhibition of stromal collagen receptor impairs breast cancer metastasis. Poster session presented at British Association of Cancer Research Conference , Nottingham, UK United Kingdom.
@conference{b646a9c0d7b94e5a8f522e0eb6df317a,
title = "Inhibition of stromal collagen receptor impairs breast cancer metastasis",
abstract = "The majority of cancer-related deaths are due to metastatic disease. Despite advances in identifying major drivers of primary tumour growth and the development of novel targeted therapies, there remains an unmet need to develop treatment strategies targeting metastatic disease. It is now well established that successful tumour progression involves a close crosstalk between tumour cells and the microenvironment.By combining in silico analysis, in vitro 3D (co-)culture assays and in vivo spontaneous and experimental breast cancer metastasis models we show that inhibition of the stromal collagen receptor Endo180 reduces breast cancer metastasis formation. Analyses of fibroblast gene signatures show a significant correlation of the collagen receptor Endo180 and fibroblast activation in human breast cancer data sets. Knock-down of Endo180 in normal and activated fibroblasts reduced their contractility on soft and stiff hydrogels. Interestingly these findings were independent of collagen. Endo180 knockdown fibroblasts lost the ability to modulate and contract collagen plugs and were less invasive. Furthermore, knock-down made the fibroblasts more fragile and sensitive towards stressful conditions, such as reduced serum and anchorage independent growth. In 3D co-culture spheroids assays wildtype fibroblasts enhanced tumour spheroid growth in contrast to Endo180 knock-down ones. Dissociation of these spheroids showed a reduced number of fibroblasts in Endo180 knock-down co-culture spheres.To assess the role of stromal Endo180 in vivo, mouse mammary carcinoma cells were orthotopically inoculated into BALB/c wildtype and knockout animals. Mice lacking the stromal collagen receptor had a significant reduction in primary tumour growth and spontaneous metastasis to the lungs. Experimental metastasis assays confirmed these findings. In correlation with our in vitro spheroid results, reduced fibroblasts infiltration was detected in primary tumours of Endo180 knock-out animals compared to wildtype animals.These data provide evidence that stromal Endo180 plays an essential role in efficient breast cancer metastasis establishment.",
author = "Ute Jungwirth",
year = "2019",
month = "7",
day = "3",
language = "English",
note = "British Association of Cancer Research Conference : Tumour Microenvironment ; Conference date: 01-07-2019 Through 03-07-2019",

}

TY - CONF

T1 - Inhibition of stromal collagen receptor impairs breast cancer metastasis

AU - Jungwirth, Ute

PY - 2019/7/3

Y1 - 2019/7/3

N2 - The majority of cancer-related deaths are due to metastatic disease. Despite advances in identifying major drivers of primary tumour growth and the development of novel targeted therapies, there remains an unmet need to develop treatment strategies targeting metastatic disease. It is now well established that successful tumour progression involves a close crosstalk between tumour cells and the microenvironment.By combining in silico analysis, in vitro 3D (co-)culture assays and in vivo spontaneous and experimental breast cancer metastasis models we show that inhibition of the stromal collagen receptor Endo180 reduces breast cancer metastasis formation. Analyses of fibroblast gene signatures show a significant correlation of the collagen receptor Endo180 and fibroblast activation in human breast cancer data sets. Knock-down of Endo180 in normal and activated fibroblasts reduced their contractility on soft and stiff hydrogels. Interestingly these findings were independent of collagen. Endo180 knockdown fibroblasts lost the ability to modulate and contract collagen plugs and were less invasive. Furthermore, knock-down made the fibroblasts more fragile and sensitive towards stressful conditions, such as reduced serum and anchorage independent growth. In 3D co-culture spheroids assays wildtype fibroblasts enhanced tumour spheroid growth in contrast to Endo180 knock-down ones. Dissociation of these spheroids showed a reduced number of fibroblasts in Endo180 knock-down co-culture spheres.To assess the role of stromal Endo180 in vivo, mouse mammary carcinoma cells were orthotopically inoculated into BALB/c wildtype and knockout animals. Mice lacking the stromal collagen receptor had a significant reduction in primary tumour growth and spontaneous metastasis to the lungs. Experimental metastasis assays confirmed these findings. In correlation with our in vitro spheroid results, reduced fibroblasts infiltration was detected in primary tumours of Endo180 knock-out animals compared to wildtype animals.These data provide evidence that stromal Endo180 plays an essential role in efficient breast cancer metastasis establishment.

AB - The majority of cancer-related deaths are due to metastatic disease. Despite advances in identifying major drivers of primary tumour growth and the development of novel targeted therapies, there remains an unmet need to develop treatment strategies targeting metastatic disease. It is now well established that successful tumour progression involves a close crosstalk between tumour cells and the microenvironment.By combining in silico analysis, in vitro 3D (co-)culture assays and in vivo spontaneous and experimental breast cancer metastasis models we show that inhibition of the stromal collagen receptor Endo180 reduces breast cancer metastasis formation. Analyses of fibroblast gene signatures show a significant correlation of the collagen receptor Endo180 and fibroblast activation in human breast cancer data sets. Knock-down of Endo180 in normal and activated fibroblasts reduced their contractility on soft and stiff hydrogels. Interestingly these findings were independent of collagen. Endo180 knockdown fibroblasts lost the ability to modulate and contract collagen plugs and were less invasive. Furthermore, knock-down made the fibroblasts more fragile and sensitive towards stressful conditions, such as reduced serum and anchorage independent growth. In 3D co-culture spheroids assays wildtype fibroblasts enhanced tumour spheroid growth in contrast to Endo180 knock-down ones. Dissociation of these spheroids showed a reduced number of fibroblasts in Endo180 knock-down co-culture spheres.To assess the role of stromal Endo180 in vivo, mouse mammary carcinoma cells were orthotopically inoculated into BALB/c wildtype and knockout animals. Mice lacking the stromal collagen receptor had a significant reduction in primary tumour growth and spontaneous metastasis to the lungs. Experimental metastasis assays confirmed these findings. In correlation with our in vitro spheroid results, reduced fibroblasts infiltration was detected in primary tumours of Endo180 knock-out animals compared to wildtype animals.These data provide evidence that stromal Endo180 plays an essential role in efficient breast cancer metastasis establishment.

M3 - Poster

ER -